Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Protein Networks

Protein Networks

An organism can have thousands of different proteins, and these proteins must cooperate to ensure the health of an organism. Proteins bind to other proteins and form complexes to carry out their functions. Many proteins interact with multiple other proteins creating a complex network of protein interactions.
These interactions can be represented through maps depicting protein-protein interaction networks, represented as nodes and edges. Nodes are circles that are representative of a protein,...

Drug Discovery: Overview

Drug Discovery: Overview

Drug discovery is a multifaceted process involving extensive screening, testing, and optimization of lead compounds to identify potential new drugs for therapeutic use. It combines several approaches, including screening large numbers of natural products, chemical modification of known active molecules, identification of new drug targets, and rational design based on biological mechanisms and drug-receptor structure. These approaches are carried out in both academic research laboratories and...

Pharmacogenomics: Identification of New Drug Targets

Pharmacogenomics: Identification of New Drug Targets

Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...

Pharmacodynamic Models: Direct Effect Model and Indirect Response Model

Pharmacodynamic Models: Direct Effect Model and Indirect Response Model

Pharmacodynamic models are essential tools in understanding the relationship between drug concentrations and their effects on biological systems. By characterizing the dynamics of drug action, these models guide dose selection, optimize therapeutic efficacy, and inform the development of new drugs. Two major classes of pharmacodynamic models include direct effect and indirect response models.Direct Effect ModelsDirect effect models describe the immediate relationship between drug concentration...

Pharmacodynamic Models: Additive and Proportional Drug Effect Model

Pharmacodynamic Models: Additive and Proportional Drug Effect Model

Drug response models describe how pharmacological agents interact with biological systems to produce measurable effects. Baseline responses are inherent physiological activities without a drug significantly influencing the observed pharmacological outcomes. Depending on the drug response model employed, these baseline responses may combine with the drug's effect in either an additive or proportional manner.Additive Drug Response ModelIn the additive model, the drug effect is independent of the...

Analysis of Population Pharmacokinetic Data

Analysis of Population Pharmacokinetic Data

Analysis of population pharmacokinetic data involves studying the behavior of drugs within diverse populations to understand their pharmacokinetic parameters. Traditional pharmacokinetic methods typically involve collecting samples from a few individuals and estimating these parameters. While these methods are commonly used, they have limitations in capturing the variability in drug response among individuals or heterogeneous populations. Population pharmacokinetics is employed to address these...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Distinct single-cell cellular states and ecosystems linked to HPV status distinguish therapeutic vulnerability of head and neck squamous cell carcinoma.

Communications biology·2026

Same author

Neutrophil Irgm1 ameliorates sepsis-induced myocardial dysfunction by promoting Alox15 degradation.

Redox biology·2026

Same author

Association of blood-based DNA methylation of lncRNAs with Alzheimer's disease diagnosis.

Clinical epigenetics·2025

Same author

High responsivity lateral GaN film photoconductive semiconductor switch based on sapphire substrates for high-power application.

Optics letters·2025

Same author

Deciphering the value of anoikis-related genes in prognosis, immune microenvironment, and drug sensitivity of laryngeal squamous cell carcinoma.

Pathology, research and practice·2025

Same author

Pan-cancer analyses reveal cancer-type-specific autophagy signatures with potential implications for prognosis and therapy response.

Journal of Cancer·2025

Search research articles

Related Experiment Video

Updated: Jun 5, 2026

Drug Repurposing Hypothesis Generation Using the "RE:fine Drugs" System

Drug Repurposing Hypothesis Generation Using the "RE:fine Drugs" System

Published on: December 11, 2016

A sub-pathway-based approach for identifying drug response principal network.

Xiujie Chen¹, Jiankai Xu, Bangqing Huang

¹College of Bioinformatics Science and Technology, Harbin Medical University, Harbin, China. chenxiujie@ems.hrbmu.edu.cn

Bioinformatics (Oxford, England)

|December 28, 2010

Summary

This study introduces a novel sub-pathway enrichment analysis to identify key biological networks. The approach enhances sensitivity in detecting drug response pathways, outperforming existing methods.

More Related Videos

Using Human Differentially Expressed Gene Lists to Perform Downstream Pathway Enrichment Analysis and Target Prioritization

Using Human Differentially Expressed Gene Lists to Perform Downstream Pathway Enrichment Analysis and Target Prioritization

Published on: October 3, 2025

Related Experiment Videos

Last Updated: Jun 5, 2026

Drug Repurposing Hypothesis Generation Using the "RE:fine Drugs" System

Drug Repurposing Hypothesis Generation Using the "RE:fine Drugs" System

Published on: December 11, 2016

Using Human Differentially Expressed Gene Lists to Perform Downstream Pathway Enrichment Analysis and Target Prioritization

Using Human Differentially Expressed Gene Lists to Perform Downstream Pathway Enrichment Analysis and Target Prioritization

Published on: October 3, 2025

Area of Science:

Bioinformatics
Systems Biology
Computational Biology

Background:

Biological pathways exhibit high redundancy and cross-talk, suggesting sub-pathway analysis may offer greater sensitivity.
Existing pathway enrichment methods often overlook pathway structures and sub-pathway dynamics.
Understanding these structures is crucial for effective drug response network identification.

Purpose of the Study:

To develop and validate a novel sub-pathway-based enrichment approach.
To identify drug response principal networks by considering quantitative pathway structures.
To improve the sensitivity and accuracy of pathway enrichment analysis.

Main Methods:

Development of a sub-pathway enrichment analysis method.
Incorporation of quantitative pathway structures into the analysis.
Validation using a microarray dataset of dexamethasone-treated prostate cancer cells.

Main Results:

The proposed method demonstrated higher sensitivity in identifying dexamethasone (DEX) response pathways compared to GeneTrail and DAVID.
The approach successfully identified principal components of sub-pathways and networks relevant to prostate cancer and DEX response.
Identified networks were further verified through literature retrieval, confirming biological relevance.

Conclusions:

Sub-pathway-based enrichment analysis offers a more sensitive and accurate method for identifying drug response networks.
This approach effectively captures the complexity of biological pathways for drug discovery.
The validated method provides a powerful tool for understanding drug mechanisms in diseases like prostate cancer.